Contamination of salvaged maternal blood by amniotic fluid and fetal red cells during elective Caesarean section

British Journal of Anaesthesia

Volumn 101, Issue 2, 2008, Pages 225-229

  Sullivan, I ^a   Faulds, J ^a   Ralph, C ^a  

^a ROYAL CORNWALL HOSPITAL   (United Kingdom)

Author keywords

Blood, salvage; Equipment, cell saver; Transfusion, autotransfusion

Indexed keywords

ALPHA FETOPROTEIN; BUPIVACAINE; FENTANYL; HEMOGLOBIN; HEPARIN; MORPHINE;

ADULT; AMNION FLUID; ARTICLE; ASPIRATION; BLOOD AUTOTRANSFUSION; BLOOD SALVAGE; CESAREAN SECTION; CLINICAL ARTICLE; CONTAMINATION; DEVICE; ELECTIVE SURGERY; EQUIPMENT; ERYTHROCYTE; ERYTHROCYTE COUNT; FEMALE; FETUS BLOOD; FETUS CELL; FILTER; HEMATOCRIT; HUMAN; HUMAN CELL; LEUKOCYTE COUNT; LEUKODEPLETION FILTER; MATERNAL BLOOD; OBSTETRIC ANESTHESIA; PRIORITY JOURNAL; SPINAL ANESTHESIA; SQUAMOUS CELL; SUCTION;

EID: 47249094885     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aen135     Document Type: Article

References (14)

1. Catling SJ, Williams S, Fielding A. Cell salvage in obstetrics: an evaluation of the ability of cell salvage combined with leucocyte depletion filtration to remove amniotic fluid from operative blood loss at caesarean section. Int J Obstet Anesth 1999; 8: 79-84
2. Waters JH, Biscotti C, Potter PS, Phillipson E. Amniotic fluid removal during cell salvage in the cesarean section patient. Anesthesiology 2000; 92: 1531-6
3. UK National Institute for Health and Clinical Excellence. Intraoperative Blood Cell Salvage in Obstetrics. IP Guidance Number: IPG144. Available from URL: http://www.nice.org.uk/download.aspx?o= IPG144guidance (last updated November 2005)
4. Allam J, Cox M, Yentis SM. Cell salvage in obstetrics. Int J Obstet Anesth 2008; 17: 37-45
5. Thornhill ML, O'Leary AJ, Lussos SA, Rutherford C, Johnson MD. An in-vitro assessment of amniotic fluid removal from human blood through cell saver processing. Anesthesiology 1991; 75: A830
6. Fong J, Gurewitsch ED, Kump L, Klein R. Clearance of fetal products and subsequent immunoreactivity of blood salvaged at cesarean delivery. Obstet Gynecol 1999; 93: 968-72
7. Davies S. What 'do' we know about AFE? Int J Obstet Anesth 2000; 9: 142
8. Murphy M, Pamphilon D, Weatherall D. Prenatal and childhood transfusions. In: Murph M, Pamphilon D, eds. Practical Transfusion Medicine, 2nd Edn. Oxford: Blackwell Publishing, 2005; 97-118
9. Health Protection Agency Press Statement. 4th Case of Variant CJD Infection Associated with Blood Transfusion. Available from URL: http://www.hpa.org.uk/hpa/news/articles/press_releases/2007/070118_vCJD.htm (updated January 18, 2007)
10. Catling S, Joels L. Cell salvage in obstetrics: the time has come. Int J Obstet Gynaecol 2005; 112: 131-2
11. Water JH. Indications and contraindications of cell salvage. Transfusion 2004; 44: 40S-4S
12. Catling SJ, Freites O, Krishnan S, Gibbs R. Clinical experience with cell salvage in obstetrics: 4 cases from one UK centre. Int J Obstet Anesth 2002; 11: 128-34
13. Rebarber A, Lonser R, Jackson S, Copel JA, Sipes S. The safety of intraoperative autologous blood collection and autotransfusion during cesarean section. Am J Obstet Gynecol 1998; 179: 715-20
14. Potter PS, Waters JH, Burger GA, Mraovic B. Application of cell-salvage during cesarean section. Anesthesiology 1999; 90: 619-21